Evidence map›Paper›PMID 39789488›Full record

ArticleBMC cancer2025

Cancer-related health behaviors during the COVID 19 pandemic in geographically diverse samples across the US.

Breanna B Greteman, Allison Cole, Mary E Charlton, Jackilen Shannon, Deanna Kepka, Electra D Paskett, Evelinn A Borrayo, Jamie L Studts, Hayley S Thompson, Isabel Scarinci and 23 more

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Breanna B GretemanUniversity of Iowa College of Public Health, Holden Comprehensive Cancer Center, Iowa City, IA, 52242, USA.
Allison ColeUniversity of Washington School of Medicine, Seattle, WA, 98195, USA.
Mary E CharltonUniversity of Iowa College of Public Health, Holden Comprehensive Cancer Center, Iowa City, IA, 52242, USA. mary-charlton@uiowa.edu.
Jackilen ShannonOregon Health and Science University, Knight Cancer Institute, Portland, OR, 97239, USA.
Deanna KepkaUniversity of Utah, Huntsman Cancer Institute, Salt Lake City, UT, 84112, USA.
Electra D PaskettOhio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Evelinn A BorrayoUniversity of Colorado Anschutz Medical Campus, University of Colorado Cancer Center, Aurora, CO, 80045, USA.
Jamie L StudtsUniversity of Colorado Anschutz Medical Campus, University of Colorado Cancer Center, Aurora, CO, 80045, USA.
Hayley S ThompsonWayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, 48201, USA.
Isabel ScarinciUniversity of Alabama Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, 35233, USA.
Lynn Chollet HintonUniversity of Kansas Medical Center, Kansas City, KS, 66103, USA.
Elizabeth A ChrischillesUniversity of Iowa College of Public Health, Holden Comprehensive Cancer Center, Iowa City, IA, 52242, USA.
Crystal J Garcia-AugusteUniversity of Iowa College of Public Health, Holden Comprehensive Cancer Center, Iowa City, IA, 52242, USA.
Kaila ChristiniUniversity of Utah, Huntsman Cancer Institute, Salt Lake City, UT, 84112, USA.
Heather AkerOhio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Jesse J PlascakOhio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Felicity W K HarperWayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, 48201, USA.
Monica L BaskinUniversity of Alabama Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, 35233, USA.
Sejong BaeUniversity of Alabama Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, 35233, USA.
Vishruti PandyaUniversity of Alabama Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, 35233, USA.
Young-Il KimUniversity of Alabama Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, 35233, USA.
Babalola FaseruUniversity of Kansas Medical Center, Kansas City, KS, 66103, USA.
Christie BefortUniversity of Kansas Medical Center, Kansas City, KS, 66103, USA.
Hanluen KuoUniversity of Kansas Medical Center, Kansas City, KS, 66103, USA.
Mark DignanUniversity of Kentucky, Markey Cancer Center, Lexington, KY, 40536, USA.
Juan CanedoUniversity of Kentucky, Markey Cancer Center, Lexington, KY, 40536, USA.
Victoria ChampionUniversity of Indiana, Simon Cancer Center, Indianapolis, IN, 46202, USA.
Bettina F DrakeWashington University in St. Louis School of Medicine, Alvin J. Siteman Cancer Center, St. Louis, MO, 63110, USA.
Kia L DavisWashington University in St. Louis School of Medicine, Alvin J. Siteman Cancer Center, St. Louis, MO, 63110, USA.
Debra L FriedmanVanderbilt-Ingram Cancer Center, Nashville, TN, 37232, USA.
Mohamed I ElsaidOhio State University College of Medicine, Columbus, OH, 43210, USA.
Scherezade K MamaDepartment of Health Disparities Research, University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA.
Wendy F CohnUniversity of Virginia Comprehensive Cancer Center, Charlottesville, VA, 22903, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Omer Jamy · 1985 to 2026
$165.9M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Jon C.D. Houtman · 2000 to 2026
$70.0M
Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
Alvin J. Siteman Cancer Center P30CA091842-18S2Barbara Ann Karmanos Cancer Institute P30CA022453Cancer Center, University of Colorado P30CA046934Cancer Center, University of Kansas CA168524-07S2Center for Clinical and Translational Science, Ohio State University UL1TR002733Comprehensive Cancer Center, University of Alabama at Birmingham P30CA013148-48Holden Comprehensive Cancer Center, University of Iowa 3P30CA086862Huntsman Cancer Institute, University of Utah P30CA042014Knight Cancer Institute, Oregon Health and Science University P30 CA069533-23S3NCATS NIH HHS UL1 TR002733NCI NIH HHS P30 CA013148NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA022453NCI NIH HHS P30 CA042014NCI NIH HHS P30 CA044579NCI NIH HHS P30 CA046934NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA069533NCI NIH HHS P30 CA086862NCI NIH HHS P30 CA091842NCI NIH HHS P30 CA168524NCI NIH HHS P30 CA177558University of Texas MD Anderson Cancer Center P30CA016672UVA Cancer Center P30CA044579Vanderbilt-Ingram Cancer Center P30CA068485
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic involved business closures (e.g., gyms), social distancing policies, and prolonged stressful situations that may have impacted engagement in health behaviors. Our study assessed changes in cancer-related health behaviors during the pandemic, specifically physical activity, fruit/vegetable intake, smoking/tobacco use, and alcohol consumption.

methodsEight cancer centers administered mailed/web-based/telephone surveys between June 2020 and March 2021. Surveys assessed demographics, perceptions on social distancing, and self-reported changes of behaviors (less/same/more) associated with cancer prevention or risk, e.g., physical activity, fruit/vegetable intake, tobacco/smoking use, and alcohol consumption. Descriptive analyses and logistic regression models assessed association of variables with behavior change.

resultsMost of the 21,911 respondents reported adhering to at least 4(of 5) social distancing measures (72%) and indicated social distancing was very/somewhat important to prevent the spread of COVID-19 (91%). 35% of respondents reported less physical activity, 11% reported less fruit/vegetable intake, 27% reported more smoking/tobacco use (among those who used tobacco/smoking products in past 30 days), and 23% reported more alcohol consumption (among those who reported at least 1 drink in past 30 days) than before the pandemic. Urban residence, younger age, female gender, and worse general health were associated with less physical activity, less fruit/vegetable intake, more smoking/tobacco use, and more alcohol intake. Higher educational attainment was associated with less physical activity and fruit/vegetable intake and more alcohol consumption. Reporting social distancing as important and adhering to more COVID-19 safety practices were associated with less physical activity and more alcohol consumption.

conclusionOur findings suggest that certain demographics and those who adhered to social distancing measures were more likely to self-report unfavorable changes in health behaviors during the pandemic. Future studies should examine if the behaviors returned to baseline following relief from pandemic restrictions, and if these behavior changes are associated with increased cancer incidence and mortality.

Indexed as

Alcohol DrinkingCOVID-19ExerciseHealth BehaviorNeoplasmsAdultAgedFemaleHumansMaleMiddle AgedPandemicsPhysical DistancingSARS-CoV-2SmokingSurveys and QuestionnairesBehaviorsCancerCOVID-19HealthPrevention

Identifiers

PMID39789488
PMCPMC11721185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.